help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on April 3, 2007
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2006-2509
A more recent version of this article appeared on June 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
92/6/2119    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Resmini, E.
Right arrow Articles by Ferone, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Resmini, E.
Right arrow Articles by Ferone, D.
Related Collections
Right arrow Neuroendocrinology and Pituitary
Right arrow Endocrine Oncology

Submitted on November 14, 2006
Accepted on March 27, 2007

Evidence of prolonged orocecal transit time and small intestinal bacterial overgrowth in acromegalic patients

Eugenia Resmini, Andrea Parodi, Vincenzo Savarino, Alfredo Greco, Alberto Rebora, Francesco Minuto, and Diego Ferone*

Department Endocrine & Medical Sciences and Center of Excellence for Biomedical Research (E.R., A.R., D.F., F.M.), Department of Gastroenterology (A.P., V.S., A.G.), University of Genova, Genova, Italy

* To whom correspondence should be addressed. E-mail: ferone{at}unige.it.

Context: Gastrointestinal abnormalities in acromegaly include dolichomegacolon, slow colonic transit and increased prevalence of colonic polyps. Conversely, no data are available on the small intestine.

Objective: To investigate the orocecal transit time (OCTT) and the presence of small intestinal bacterial overgrowth (SIBO).

Patients: 41 acromegalic patients and 30 sex and age matched control subjects entered the study. Acromegalic patients were classified according to the medical treatment with somatostatin analogs as "treated" (n = 22) and "untreated" (n = 19), whereas according to the disease control, as "controlled" (n = 17), "uncontrolled" (n = 10) and "partially controlled" (n = 14). Patients and controls completed a questionnaire and underwent to a standardized 10 g lactulose hydrogen (H2) breath test (LH-BT) to determine the OCTT and presence of SIBO. SIBO-positive patients underwent to eradication with rifaximine.

Results: An increased prevalence of SIBO (18/41 vs. 1/30, P < 0.0001) and a significantly delayed OCTT (169.53 ± 8.15 vs. 107.25 ± 6.56 min, P < 0.0001) was evidenced in patients compared with controls. No significant statistical differences were found between "treated" or "untreated" patients positive for SIBO, neither between "controlled", "partially controlled" and "uncontrolled" patients. OCTT was significantly delayed in "treated" vs. "untreated" patients (183.21 ± 9.01 and 158.89 ± 6.38 respectively, P = 0.02), and in patients compared with controls (105.75 ± 6.34, P < 0.0001). Rifaximine eradicated SIBO in more than 50% of patients underwent to treatment.

Conclusion: These data demonstrate for the first time that SIBO occurs more frequently in acromegalic patients, however, it can be successfully treated by a specific antibiotic. Medical therapy with somatostatin analogs does not affect SIBO prevalence. OCTT resulted significantly prolonged in both "treated" and "untreated" patients, suggesting that acromegaly determines per se an impairment of the intestinal motility. Indeed, disease control seems irrelevant on the delayed OCTT, suggesting that this alteration might be an irreversible complication of acromegaly, probably related to an autonomic intestinal disorder, as we have previously demonstrated at cardiac level.


Key words: Acromegaly • orocecal transit time • small intestine bacterial overgrowth • somatostatin analogs • GH




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
A. Tagliafico, E. Resmini, R. Nizzo, F. Bianchi, F. Minuto, D. Ferone, and C. Martinoli
Ultrasound Measurement of Median and Ulnar Nerve Cross-Sectional Area in Acromegaly
J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 905 - 909.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society